TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 61 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,912,186 | -40.8% | 103,744 | 0.0% | 0.50% | -40.2% |
| Q2 2023 | $6,613,100 | +156.7% | 103,744 | -2.0% | 0.84% | +128.9% |
| Q1 2023 | $2,575,828 | -16.3% | 105,914 | 0.0% | 0.37% | -9.6% |
| Q4 2022 | $3,075,743 | -41.5% | 105,914 | -39.7% | 0.41% | -73.4% |
| Q3 2022 | $5,262,000 | -16.1% | 175,520 | +1.2% | 1.52% | +27.0% |
| Q2 2022 | $6,274,000 | -10.9% | 173,520 | +6.6% | 1.20% | -10.6% |
| Q1 2022 | $7,039,000 | -11.8% | 162,703 | +2.2% | 1.34% | +77.5% |
| Q4 2021 | $7,978,000 | +25.4% | 159,203 | +59.2% | 0.76% | -76.1% |
| Q3 2021 | $6,363,000 | -11.6% | 100,000 | 0.0% | 3.16% | +22.3% |
| Q2 2021 | $7,196,000 | – | 100,000 | – | 2.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |